Filter Results
:
(1,095)
Show Results For
-
All HBS Web
(1,095)
- People (2)
- News (285)
- Research (594)
- Multimedia (12)
- Faculty Publications (243)
Show Results For
-
All HBS Web
(1,095)
- People (2)
- News (285)
- Research (594)
- Multimedia (12)
- Faculty Publications (243)
- 10 Jun 2021
- News
Preparing Hospitals for the Next Pandemic
- January 2014 (Revised June 2014)
- Case
23andMe: Genetic Testing for Consumers (A)
By: John A. Quelch and Margaret L. Rodriguez
On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was...
View Details
Keywords:
Public Health;
Genome Testing;
Health Care;
Ancestry;
23andMe;
Marketing;
Product Launch;
Health;
Health Care and Treatment;
Health Testing and Trials;
Genetics;
Strategy;
Health Industry;
United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (A)." Harvard Business School Case 514-086, January 2014. (Revised June 2014.)
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Health Care and Treatment;
Technology Adoption;
Technological Innovation;
Safety;
Medical Devices and Supplies Industry;
United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
Preparing Hospitals for the Next Pandemic
The Covid-19 epidemic response has shown that the U.S. is blessed with heroic physicians and other health care providers, researchers, and facilities. But it has also revealed a health care system that was woefully unprepared for the surge of pandemic patients. In the...
View Details
- 02 Oct 2006
- Research & Ideas
Negotiating in Three Dimensions
"interests," or what each side really cares about. Failure to uncover interests often leads to mistakes in our second dimension, deal design, such as treating potentially more cooperative...
View Details
Keywords:
by Martha Lagace
- Research Summary
Fairness and Efficiency in Resource Allocation
In studying the relationship of fairness and efficiency, Professor Trichakis takes the novel approach of looking at varied industries for unifying factors, and he pays special attention to inequities by incorporating both quantitative work in social welfare and the... View Details
- Article
Assessing the Food and Drug Administration's Risk-Based Framework for Software Precertification with Top Health Apps in the United States: Quality Improvement Study
By: Noy Alon, Ariel Dora Stern and John Torous
BACKGROUND: As the development of mobile health apps continues to accelerate, the need to implement a framework that can standardize categorizing these apps to allow for efficient, yet robust regulation grows. However, regulators and researchers are faced with numerous...
View Details
Keywords:
Mobile Health;
Smartphone;
Food And Drug Administration;
Risk-based Framework;
Health Care and Treatment;
Mobile and Wireless Technology;
Applications and Software;
Framework
Alon, Noy, Ariel Dora Stern, and John Torous. "Assessing the Food and Drug Administration's Risk-Based Framework for Software Precertification with Top Health Apps in the United States: Quality Improvement Study." JMIR mHealth and uHealth 8, no. 10 (October 2020).
- February 24, 2022
- Article
Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC
By: Regina E. Herzlinger and Richard Boxer
During the initial phases of the COVID-19 pandemic, many U.S. hospitals could not provide enough beds to meet demand. Solving the problem of inadequate capacity is of utmost importance in the “new normal,” which requires recognizing the ongoing need for hospital-based...
View Details
Keywords:
COVID;
COVID-19 Pandemic;
Hospital Capacity;
SEC Regulation;
Health Pandemics;
Crisis Management;
Performance Capacity;
Planning
Herzlinger, Regina E., and Richard Boxer. "Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC." Harvard Business School Working Knowledge (February 24, 2022).
- September 2014 (Revised May 2017)
- Case
Fresno's Social Impact Bond for Asthma
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Social Impact Bonds (SIBs) were quickly gaining popularity as an investment vehicle which joined together private investors and nonprofits to tackle social issues. Although numerous SIB projects and proposals had cropped up across the U.S. following the launch...
View Details
Keywords:
Social Enterprise;
Health Care;
Marketing;
Bonds;
Financing;
Asthma;
Air Pollution;
Air Quality;
Chronic Disease;
Public Health;
Health;
Health Care and Treatment;
Finance;
Health Industry;
Financial Services Industry;
United States
Quelch, John A., and Margaret L. Rodriguez. "Fresno's Social Impact Bond for Asthma." Harvard Business School Case 515-028, September 2014. (Revised May 2017.)
- December 2017 (Revised April 2018)
- Case
The Children's Hospital of Philadelphia: Network Strategy 2016
By: Michael E. Porter, Thomas W. Feeley and Toyin J. Okanlawon
Children’s Hospital of Philadelphia (CHOP) began as a stand-alone hospital in the heart of downtown Philadelphia in 1855. By 2016 the CHOP Care Network stretched across Pennsylvania, New Jersey, and the New York metropolitan area, providing a wide range of services...
View Details
Keywords:
Communication;
Health Care and Treatment;
Service Delivery;
Organizational Structure;
Networks;
Integration;
Strategy;
Health Industry;
Philadelphia
Porter, Michael E., Thomas W. Feeley, and Toyin J. Okanlawon. "The Children's Hospital of Philadelphia: Network Strategy 2016." Harvard Business School Case 718-420, December 2017. (Revised April 2018.)
- Web
Why Plume? To Make a Difference in the World - MBA
East and North Africa South America United States 23 Jul 2020 Why Plume? To Make a Difference in the World Soltan Bryce Author MBA Students tag Entrepreneurship Health Care /...
View Details
- 07 Jun 2016
- First Look
June 7, 2016
strategic, financial, and operational objectives. Publisher's link: https://pubwww.hbs.edu/faculty/Pages/item.aspx?num=51110 May 2016 Oncology How the Affordable Care Act Has Affected View Details
Keywords:
Sean Silverthorne
- August 2012 (Revised January 2013)
- Case
Public Health Insurance Exchanges: The Massachusetts Experience
By: Regina Herzlinger and Jordan Bazinsky
The CEO of Tufts Health Plan, James Roosevelt, is wondering whether to offer insurance products on the Massachusetts Connector, the first U.S. exchange. He wonders if he should enter these uncharted waters at all. And, if yes, with a broad network or a narrow network...
View Details
- 25 Jul 2009
- News
Some Inconvenient Truths About Medicare and the New 'Public Plan'
- 02 Sep 2022
- News
Strength in Numbers
ineffective.” Their solution? The Goodness Web, a nonprofit that finds its strength in connection, in “a web of people who can aggregate resources—whether that is philanthropic...
View Details
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other...
View Details
Keywords:
Trichloroethylene;
Toxicity;
Lobbying;
Chemicals;
Health Disorders;
Governing Rules, Regulations, and Reforms;
Policy;
Ethics;
Business and Government Relations;
Chemical Industry;
United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- June 2018
- Teaching Note
Sandra Brown Goes Digital
By: Rosabeth Moss Kanter and Jonathan Cohen
As a middle manager at a biotechnology company, Sandra Brown harnessed digital tools and social media to engage others and build campaigns for change in the company. This Teaching Note presents strategies for teaching the Sandra Brown case series, which follows Brown's...
View Details
- March 2023 (Revised March 2024)
- Case
The Purdue Pharma Bankruptcy: Settling the Opioid Crisis
By: Kristin Mugford, Carin-Isabel Knoop and Susan Pinckney
How to get to a fair outcome for claimants in the Purdue Pharma bankruptcy given its significant role in the U.S. opioid crisis.
View Details
Keywords:
Regulation;
Ethics;
Fairness;
Insolvency and Bankruptcy;
Government Legislation;
Courts and Trials;
Laws and Statutes;
Lawsuits and Litigation;
Legal Liability;
Crime and Corruption;
Negotiation Offer;
Negotiation Participants;
Negotiation Style;
Product Design;
Product Development;
Brands and Branding;
Marketing Strategy;
Trust;
Government and Politics;
Law;
Negotiation;
Operations;
Ownership;
Marketing;
Social Psychology;
Health Care and Treatment;
Pharmaceutical Industry;
United States
Mugford, Kristin, Carin-Isabel Knoop, and Susan Pinckney. "The Purdue Pharma Bankruptcy: Settling the Opioid Crisis." Harvard Business School Case 223-060, March 2023. (Revised March 2024.)
- February 2001 (Revised February 2002)
- Case
Estee Lauder and the Market for Prestige Cosmetics
By: Nancy F. Koehn
Opens with a brief history of the U.S. cosmetics market and its rapid development in the 1920s. Also recounts Lauder's initial involvement in the sector, making skin care products and selling them in Manhattan beauty parlors during the Great Depression. Pays particular...
View Details
Keywords:
Fluctuation;
Organizational Change and Adaptation;
Market Entry and Exit;
Entrepreneurship;
Luxury;
Business Strategy;
Society;
Beauty and Cosmetics Industry;
United States
Koehn, Nancy F. "Estee Lauder and the Market for Prestige Cosmetics." Harvard Business School Case 801-362, February 2001. (Revised February 2002.)
- 18 Nov 2021
- News
Strength in Numbers
American Cancer Society for the mental health field—an organization that can increase awareness, reduce the stigma, and rally donors to make large, multiyear funding...
View Details
Keywords:
April White